Brief: PledPharma Q3 Loss Narrows To SEK 24.7 Mln
Nov 11 (Reuters) - PledPharma AB (publ) PLED.ST :
* INTERIM REPORT JANUARY 1-SEPTEMBER 30, 2020
* Q3 NET SALES SEK 2.6 MILLION VERSUS SEK 6.2 MILLION YEAR
AGO
* Q3 LOSS SEK 24.7 MILLION VERSUS LOSS SEK 31.9 MILLION YEAR
AGO
Source text for Eikon: ID:nNDL5CSJQf
Further company coverage: PLED.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Egetis Therapeutics AB (publ)
See all newsBrief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln
Brief: Egetis Plans Directed Share Issue Raising SEK 350 Million
Brief: Egetis Therapeutics Appoints Tiago Nunes As CMO Effective May 1